Pharmacokinetics of Single and Multiple Oral Doses of 120 mg and 240 mg BI 201335 in Healthy Chinese Volunteers
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2015
At a glance
- Drugs Faldaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Apr 2013 New trial record